Evaluating expression of TAZ and YAP in multiple histological types of sarcoma revealed that approximately 50% of sarcoma clinical samples demonstrate activated YAP, while 66% demonstrate activated TAZ. This evidence concerns the gene YAP1 and sarcoma.